Sagent Pharmaceuticals, Inc. (SGNT) Earnings
|
Expand Research on SGNT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1,088.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/3/16 | Q116 | -$0.15 | $0.01 | -$0.16 | $67.3M | $74.3M | N/A |  | | Details | |
2/16/16  |
Q415 | -$0.55 | -$0.02 | -$0.53 | $83.1M | $78.13M | N/A | | | Details | |
| 11/3/15 |
Q315 | -$0.05 | -$0.06 | +$0.01 | $75.2M | $73.84M | N/A | | | Details | |
| 8/4/15 |
 |
Q215 | -$0.01 | $0.05 | -$0.06 | $77.3M | $83.28M | N/A | | | Details |
| 5/5/15 |
|
Q115 | -$0.06 | $0.04 | -$0.10 | $82.6M | $80.63M | N/A | | | Details |
| 2/19/15 |
|
Q414 | $0.91 | $0.01 | +$0.90 | $84.4M | $76.2M | N/A | | | Details |
| 11/4/14 |
|
Q314 | $0.06 | -$0.04 | +$0.10 | $65.4M | $64.01M | N/A | | | Details |
| 7/30/14 |
|
Q214 | $0.09 | -$0.01 | +$0.10 | $69.2M | $67.14M | N/A | | | Details |
